NCT05083208 2025-12-02
PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Henan Cancer Hospital
Phase 1 Terminated
Henan Cancer Hospital
Azienda USL Reggio Emilia - IRCCS
Azienda USL Reggio Emilia - IRCCS